Alphatec Holdings, Inc. (ATEC)

Market Cap	1.68B +11.5%
Revenue (ttm)	764.16M +25.0%
Net Income	-143.36M
EPS	-0.96
Shares Out	151.36M
PE Ratio	n/a
Forward PE	38.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,560,309
Open	11.17
Previous Close	10.82
Day's Range	10.98 - 11.43
52-Week Range	10.06 - 23.29
Beta	1.12
Analysts	Strong Buy
Price Target	22.00 (+98.2%)
Earnings Date	May 4, 2026

About ATEC

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-o...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 2, 2006
• Employees: 913
• Stock Exchange: NASDAQ
• Ticker Symbol: ATEC
• Website: https://www.atecspine.com

Financial Performance

In 2025, Alphatec Holdings's revenue was $764.16 million, an increase of 24.95% compared to the previous year's $611.56 million. Losses were -$143.36 million, -11.57% less than in 2024.

Analyst Summary

According to 11 analysts, the average rating for ATEC stock is "Strong Buy." The 12-month stock price target is $22.0, which is an increase of 98.20% from the latest price.

Price Target

$22.0

(98.20% upside)

Analyst Consensus: Strong Buy